Supplementary Table S3 from Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers
Authors:
- Patricia J. KellerPKPatricia J. Keller
- Elizabeth J. AdamsEAElizabeth J. Adams
- Rentian WuRWRentian Wu
- Alexandre CôtéACAlexandre Côté
- Shilpi AroraSAShilpi Arora
- Nico CantoneNCNico Cantone
- Rosana MeyerRMRosana Meyer
- Jennifer A. MertzJMJennifer A. Mertz
- Victor GehlingVGVictor Gehling
- Jike CuiJCJike Cui
- Jacob I. StuckeyJSJacob I. Stuckey
- Avinash KhannaAKAvinash Khanna
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)